Physician profile
Maryann E Millar
NPI 1417964990
$1,626.08
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $952 · 2020: $24.25 · 2021: $650.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $650.00 | 2021 | |
| Gen-Probe, INC. | $557.78 | 2019 | |
| Covidien LP | $152.50 | 2019 | |
| Teleflex LLC | $75.41 | 2019 | |
| Coopersurgical, INC. | $40.35 | 2019 | |
| Vertical Pharmaceuticals, LLC | $35.26 | 2019 | |
| Therapeuticsmd, INC. | $25.71 | 2019 | |
| Allergan, INC. | $24.25 | 2020 | |
| Abbvie INC. | $19.23 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.87 | 2019 | |
| Pfizer INC. | $15.07 | 2019 | |
| Avion Pharmaceuticals | $14.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryann Millar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.